Valley National Advisers’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-3
| Closed | -$1K | – | 957 |
|
|
2021
Q1 | $1K | Hold |
3
| – | – | ﹤0.01% | 836 |
|
|
2020
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 885 |
|
|
2020
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 869 |
|
|
2020
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 889 |
|
|
2020
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 879 |
|
|
2019
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 848 |
|
|
2019
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 849 |
|
|
2019
Q2 | $1K | Hold |
3
| – | – | ﹤0.01% | 715 |
|
|
2019
Q1 | $1K | Hold |
3
| – | – | ﹤0.01% | 716 |
|
|
2018
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 849 |
|
|
2018
Q3 | $1K | Hold |
3
| – | – | ﹤0.01% | 666 |
|
|
2018
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 730 |
|
|
2018
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 718 |
|
|
2017
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 738 |
|
|
2017
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 716 |
|
|
2017
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 663 |
|
|
2017
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 692 |
|
|
2016
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 782 |
|
|
2016
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 754 |
|
|
2016
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 668 |
|
|
2016
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 680 |
|
|
2015
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 670 |
|
|
2015
Q3 | $0 | Buy |
+3
| New | +$334 | ﹤0.01% | 661 |
|
Other funds holding GWPH
Valley National Advisers's GWPH Position: Q2 2021 in Review
Valley National Advisers sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 3 shares — an estimated $1K sold.
Valley National Advisers first reported a position in GWPH in Q3 2015 and held it in 23 quarters. The position peaked at $1K in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.
- Valley National Advisers reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
- Valley National Advisers sold 3 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $1K.
- Valley National Advisers first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2015 and held it in 23 quarters.
- Valley National Advisers's GW Pharmaceuticals Plc American Depositary Shares position peaked at $1K in Q1 2021.
- 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.
Based on Valley National Advisers's 13F filing for Q2 2021, filed 2 Aug 2021.